# Sugammadex and Neostigmine in Pediatric Patients

> **NCT05618236** · — · COMPLETED · sponsor: **Marmara University** · enrollment: 130 (actual)

## Conditions studied

- Postoperative Vomiting
- Postoperative Nausea
- Postoperative Delirium

## Interventions

- **DRUG:** Group N; neostigmine+atropine
- **DRUG:** GROUP S; decurarized with sugammadex.

## Key facts

- **NCT ID:** NCT05618236
- **Lead sponsor:** Marmara University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-08
- **Primary completion:** 2023-10-25
- **Final completion:** 2024-04-15
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618236, "Sugammadex and Neostigmine in Pediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05618236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*